This webinar focuses on the baseline assessment of shortness of breath and the association with early or established interstitial lung disease.
Learning Objectives
Dr Vasilis Kouranos Background
Dr Vasilis Kouranos is highly specialised in pulmonary fibrosis and interstitial lung diseases such as idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and connective tissue disease-associated interstitial lung diseases at Royal Brompton Hospital.
He has sub-specialist expertise in sarcoidosis and particularly cardiac sarcoidosis, which was the subject of his PhD thesis. He also offers clinical support for sarcoidosis and ILD patients with lung cancer.
This talk provides an overview of the management and prognosis of rare lung diseases, looking at the differential diagnosis in detail.
This talk provides an overview of TAVI, delving into what the future holds and what has been accomplished to date.
Our consultant respiratory physician, Dr Vasilis Kouranos, provides an overview on how to treat and monitor patients presenting sarcoidosis.
Professor Sébastien Gagneux provides an overview of tuberculosis (TB), delving into the reasons on how TB becomes resistant in individuals.
Professor Andrew Menzies-Gow discusses maintenance of oral corticosteroids for severe eosinophilic asthma, overviewing the PONENTE study.
Our consultant cardiothoracic radiologist, Dr Tarun Mittal looks at appropriate uses of imaging in patients with stable chest pain in cardiac CT, stress imaging, etc as per NICE recommendations.
This talk discusses pulmonary hypertension in advanced lung diseases, focusing on the evolving treatment options in continual clinical trials.
This talk provides an overview on ARDS, ECMO and COVID-19 and the effects of severe respiratory failure on patient outcomes.
Dr Antonis Pantazis covers the importance of having a holistic approach to hypertrophic cardiomyopathy.
This talk focuses on the topic of recurrent respiratory tract infections.
Dr Adam Laing discusses how his research team has used novel high-throughput flow cytometry to dissect clinical heterogeneity to understand the immune signature of COVID-19 during acute infection and the potential applicability to other cardiorespiratory.